Keyphrases
Acute Myocardial Infarction
14%
Acute Respiratory Distress Syndrome
13%
Age Trends
15%
Age-related Illnesses
17%
All-cause Mortality
14%
Aortic Stenosis
13%
Cardiac Surgery
33%
Cardiovascular Outcomes
13%
Cognitive Impairment
13%
Confidence Interval
44%
Coronary Angiography
15%
Coronary Artery Disease
25%
Delirium
18%
Economic Burden
13%
Femoral Access
23%
Frail Elderly
25%
Frailty
61%
Hazard Ratio
13%
Health Trends
15%
Hierarchical Development
13%
Individualized Care
13%
Inpatient Care
13%
Intervention Outcome
13%
Major Adverse Cardiovascular Events
14%
Maryland
33%
Meta-analysis
40%
Meta-analysis of Randomized Controlled Trials
26%
Mitral Regurgitation
13%
Myocardial Injury
14%
National Health
15%
Non-frail
22%
Non-primary
26%
Older Adults
18%
Percutaneous Coronary Intervention
31%
Phenotypic Frailty
15%
Physical Frailty
14%
Poor Outcome
14%
Post-cardiac Surgery
13%
Radial Access
26%
Randomized Clinical Trial
15%
Risk Difference
14%
Risk Ratio
24%
Secondary Access
13%
Severe Coronavirus Disease 2019
13%
Statins
13%
Surgical Aortic Valve Replacement
26%
Systematic Meta-analysis
52%
Ticagrelor
26%
Transcatheter Aortic Valve Replacement
85%
Trend Study
15%
Medicine and Dentistry
Acute Heart Infarction
14%
Acute Respiratory Distress Syndrome
13%
Adverse Outcome
15%
Aortic Stenosis
29%
Aortic Valve Replacement
34%
Apoplexy
16%
Arginase
13%
Atrial Fibrillation
13%
Attributable Risk
13%
Bleeding
14%
Cardiomyopathy
10%
Cardiovascular Disease
36%
Cardiovascular Disease Prevention
13%
Cardiovascular System
27%
Cognitive Defect
13%
Coronary Angiography
14%
Coronary Artery Fistula
13%
COVID-19
13%
Fibrosis
13%
Fistula
13%
Frailty
65%
Geriatric Syndrome
14%
Hazard Ratio
16%
Heart Muscle Contractility
13%
Heart Muscle Injury
13%
Heart Surgery
14%
Hospital Management
13%
Hospital Mortality
10%
Hyperlipidemia
13%
Infective Endocarditis
13%
Ischemic Heart Disease
19%
Low Density Lipoprotein Cholesterol
13%
Major Adverse Cardiac Event
10%
Major Bleeding
15%
Meta-Analysis
52%
Mitral Insufficiency
13%
Myocardial Infarction
14%
Neuronal Nitric Oxide Synthase
13%
Odds Ratio
20%
Percutaneous Aortic Valve Replacement
100%
Percutaneous Coronary Intervention
30%
Primary Prevention
17%
Right Coronary Artery
13%
Sarcopenia
13%
Silo-Filler's Disease
13%
Statin
19%
Superior Vena Cava
13%
Systematic Review
52%
Target Vessel Revascularization
16%
Vascular Stent
13%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
7%
Acute Coronary Syndrome
13%
Acute Heart Infarction
14%
Acute Kidney Failure
10%
Adult Respiratory Distress Syndrome
13%
Adverse Event
6%
Adverse Outcome
20%
All Cause Mortality
24%
Antiplatelet
13%
Aortic Stenosis
41%
Arginase
13%
Atrial Fibrillation
13%
Bivalirudin
13%
Bleeding
32%
Cardiomyopathy
13%
Cardiovascular Disease
32%
Cardiovascular Mortality
20%
Clinical Trial
7%
Comorbidity
13%
Contrast Induced Nephropathy
6%
Coronavirinae
13%
Delirium
17%
Disease
29%
Duragesic
13%
Emphysema
8%
Fibrosis
13%
Frailty
39%
Heart Infarction
24%
Heart Muscle Injury
14%
Heparin
13%
Ischemic Heart Disease
6%
Lotus (Genus)
6%
Lung Disease
13%
Neuronal Nitric Oxide Synthase
13%
Observational Study
39%
Paravalvular Leak
8%
Prasugrel
13%
Prevalence
7%
Randomized Clinical Trial
14%
Randomized Controlled Trial
41%
ST Segment Elevation Myocardial Infarction
13%
Statin (Protein)
13%
Stent Thrombosis
10%
Synthetase
7%
Ticagrelor
26%
Transient Ischemic Attack
6%
